140 related articles for article (PubMed ID: 28814542)
1. Fragile X Newborn Screening: Lessons Learned From a Multisite Screening Study.
Bailey DB; Berry-Kravis E; Gane LW; Guarda S; Hagerman R; Powell CM; Tassone F; Wheeler A
Pediatrics; 2017 Jun; 139(Suppl 3):S216-S225. PubMed ID: 28814542
[TBL] [Abstract][Full Text] [Related]
2. Newborn, carrier, and early childhood screening recommendations for fragile X.
Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
[TBL] [Abstract][Full Text] [Related]
3. Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project.
Skinner D; Choudhury S; Sideris J; Guarda S; Buansi A; Roche M; Powell C; Bailey DB
Pediatrics; 2011 Jun; 127(6):e1455-63. PubMed ID: 21624881
[TBL] [Abstract][Full Text] [Related]
4. Simple molecular diagnostic method for fragile X syndrome in Egyptian patients: pilot study.
Meguid NA; Ismail MF; El-Mahdy RS; Barakat MA; El-Awady MK
Acta Biochim Pol; 2014; 61(2):259-63. PubMed ID: 24936518
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Fragile X Syndrome Newborn Screening Landscape.
Riley C; Wheeler A
Pediatrics; 2017 Jun; 139(Suppl 3):S207-S215. PubMed ID: 28814541
[TBL] [Abstract][Full Text] [Related]
6. Maternal attitudes to newborn screening for fragile X syndrome.
Christie L; Wotton T; Bennetts B; Wiley V; Wilcken B; Rogers C; Boyle J; Turner C; Hansen J; Hunter M; Goel H; Field M
Am J Med Genet A; 2013 Feb; 161A(2):301-11. PubMed ID: 23303663
[TBL] [Abstract][Full Text] [Related]
7. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for fragile X syndrome.
Tassone F
JAMA Neurol; 2014 Mar; 71(3):355-9. PubMed ID: 24395328
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis and carrier screening for fragile X by PCR.
Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
[TBL] [Abstract][Full Text] [Related]
10. Pediatricians' knowledge of and attitudes toward fragile X syndrome screening.
Kemper AR; Bailey DB
Acad Pediatr; 2009; 9(2):114-7. PubMed ID: 19329102
[TBL] [Abstract][Full Text] [Related]
11. Newborn screening for fragile X syndrome.
Bailey DB
Ment Retard Dev Disabil Res Rev; 2004; 10(1):3-10. PubMed ID: 14994282
[TBL] [Abstract][Full Text] [Related]
12. Screening for Fragile X Syndrome: parent attitudes and perspectives.
Skinner D; Sparkman KL; Bailey DB
Genet Med; 2003; 5(5):378-84. PubMed ID: 14501833
[TBL] [Abstract][Full Text] [Related]
13. Incidence of fragile X in 5,000 consecutive newborn males.
Rifé M; Badenas C; Mallolas J; Jiménez L; Cervera R; Maya A; Glover G; Rivera F; Milà M
Genet Test; 2003; 7(4):339-43. PubMed ID: 15000813
[TBL] [Abstract][Full Text] [Related]
14. Checklist assessments of FMR1 gene mutation phenotypes.
Johnson VA
J Cult Divers; 2008; 15(3):117-31. PubMed ID: 19025200
[TBL] [Abstract][Full Text] [Related]
15. Prenatal carrier testing for fragile X: counseling issues and challenges.
Musci TJ; Moyer K
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan.
Chow JC; Chen DJ; Lin CN; Chiu CY; Huang CB; Chiu PC; Lin CH; Lin SJ; Tzeng CC
J Formos Med Assoc; 2003 Jan; 102(1):12-6. PubMed ID: 12684606
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of fragile X syndrome].
Glover G; Bernabé MJ; Carbonell P
Rev Neurol; 2001 Oct; 33 Suppl 1():S6-9. PubMed ID: 12447811
[TBL] [Abstract][Full Text] [Related]
18. No change in the age of diagnosis for fragile x syndrome: findings from a national parent survey.
Bailey DB; Raspa M; Bishop E; Holiday D
Pediatrics; 2009 Aug; 124(2):527-33. PubMed ID: 19581269
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the polymerase chain reaction-based screening and the Southern blot methods for identification of fragile X syndrome.
Curtis-Cioffi KM; Rodrigueiro DA; Rodrigues VC; Cicarelli RM; Scarel-Caminaga RM
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1303-8. PubMed ID: 23101592
[TBL] [Abstract][Full Text] [Related]
20. Advanced technologies for the molecular diagnosis of fragile X syndrome.
Tassone F
Expert Rev Mol Diagn; 2015; 15(11):1465-73. PubMed ID: 26489042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
